SNOA
SNOA
NASDAQ · Pharmaceuticals

Sonoma Pharmaceuticals Inc

$1.11
+0.04 (+3.74%)
As of Nov 7, 2:52 AM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,064.9% upside
Low Target $7.21
Average Target $12.93
High Target $14.12
Current Price $1.11
Current
$1.11
Target
$12.93
$7.21 $12.93 avg $14.12
Scenario Analysis
Bear Case
$7.21
549.5%
Low target
Base Case
$12.93
+1,064.9%
Avg target
Bull Case
$14.12
+1,172.1%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$3.95
-71.9% from high
52-Week Low
$0.85
+30.6% from low
Target vs 52W High
$12.93
+227.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%